title: Efavirenz (Sustiva) on fast-track for FDA accelerated approval. Food and Drug Administration.
authors.forename: R
authors.initials: R
authors.lastname: Baker
mesh_terms: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D017277:Drug Approval; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010078:Oxazines / Q000008:administration & dosage / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz